Skip to main content
Clinical Trials/JPRN-UMIN000022238
JPRN-UMIN000022238
Completed
未知

Prognostic value of minimal residual disease detection by multiparameter flow cytometry (EuroFlow method) in patients with multiple myeloma who underwent autologous stem cell transplantation: comparison with sequencing-based method - Prognostic value of MRD detection by MFC in MM patients who underwent ASCT: comparison with NGS

Kanazawa University0 sites66 target enrollmentMay 23, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
multiple myeloma
Sponsor
Kanazawa University
Enrollment
66
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 23, 2016
End Date
December 31, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • The patients who the physicians in charge judge to be inappropriate to participate in this trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials